Litcius/Paper detail

MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury

Qing Yin, Yajie Zhao, Wei‐Jie Ni, Tao‐Tao Tang, Yao Wang, Jing-Yuan Cao, Di Yin, Yi Wen, Zuo‐Lin Li, Yilin Zhang, Wei Jiang, Yue Zhang, Xiaoyu Lu, Aiqing Zhang, Wei-Hua Gan, Lin‐Li Lv, Bi‐Cheng Liu, Bin Wang

2022Theranostics43 citationsDOIOpen Access PDF

Abstract

Rationale: Cisplatin nephrotoxicity is an important cause of acute kidney injury (AKI), limiting cisplatin application in cancer therapy. Growing evidence has suggested that genome instability, telomeric dysfunction, and DNA damage were involved in the tubular epithelial cells (TECs) damage in cisplatin-induced AKI (cAKI). However, the exact mechanism is largely unknown. Methods: We subjected miR-155 -/-mice and wild-type controls, as well as HK-2 cells, to cAKI models. We assessed kidney function and injury with standard techniques. The cell apoptosis and DNA damage of TECs were evaluated both in vivo and in vitro. Telomeres were measured by the fluorescence in situ hybridization.

Topics & Concepts

DNA damageCisplatinGenome instabilityApoptosisCancer researchAcute kidney injuryDNA repairBiologyNephrotoxicityIn vivoKidneyCell biologyMolecular biologyMedicineDNAGeneticsChemotherapyInternal medicineChemotherapy-induced organ toxicity mitigationRenal and related cancersArsenic contamination and mitigation
MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury | Litcius